Preventing Left Ventricular Hypertrophy by ACE Inhibition in Hypertensive Patients With Type 2 Diabetes: A prespecified analysis of the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT)

OBJECTIVE—In patients with type 2 diabetes, left ventricular hypertrophy (LVH) predicts cardiovascular events, and the prevention of LVH is cardioprotective. We sought to compare the effect of ACE versus non-ACE inhibitor therapy on incident electrocardiographic (ECG) evidence of LVH (ECG-LVH). RESE...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ruggenenti, Piero, Iliev, Ilian, Costa, Grazia Maria, Parvanova, Aneliya, Perna, Annalisa, Giuliano, Giovanni Antonio, Motterlini, Nicola, Ene-Iordache, Bogdan, Remuzzi, Giuseppe
Formato: Artigo
Idioma:Inglês
Publicado em: American Diabetes Association 2008
Assuntos:
Cardiovascular and Metabolic Risk
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2494629/
https://ncbi.nlm.nih.gov/pubmed/18443191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc08-0371
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados